SBC Medical Group Holdings (NASDAQ: SBC) has been showing strong financial performance, with its Return on Capital Employed (ROCE) rising to 12%, surpassing the industry average of 9%. This suggests improved capital efficiency and potential long-term growth. Morningstar Research has assigned a fair value of $6.13 per share, indicating a promising valuation. But is SBC a smart investment? Watch this analysis to find out.
Koa International
The goal of Koa International is to bring stories to you, to help make decisions, lighten your day or gain insight into areas of interest. Through stories, we learn, absorb and retain information and shaping our own perspective.
Latest
Bintai Kinden Reports FYE2025 Results, Marks Completion of Regularisation Plan
Bintai Kinden Corporation Berhad ("BKCB" or the "Company"; Bursa: BINTAI,...
Advancecon Continues Contract Win Momentum with RM68.5 Million Contract from Sime Darby Property
Advancecon Holdings Berhad (前进控股有限公司) (“Advancecon” or “the Group”) (Bursa:...
AmanahRaya REIT Delivers Strong Q1 FY2025 Performance with 69.0% Growth in Realised Income Before Tax
AmanahRaya Real Estate Investment Trust (“AmanahRaya REIT”) reported its financial...
Popular
Bintai Kinden Reports FYE2025 Results, Marks Completion of Regularisation Plan
Bintai Kinden Corporation Berhad ("BKCB" or the "Company"; Bursa: BINTAI,...
Advancecon Continues Contract Win Momentum with RM68.5 Million Contract from Sime Darby Property
Advancecon Holdings Berhad (前进控股有限公司) (“Advancecon” or “the Group”) (Bursa:...
AmanahRaya REIT Delivers Strong Q1 FY2025 Performance with 69.0% Growth in Realised Income Before Tax
AmanahRaya Real Estate Investment Trust (“AmanahRaya REIT”) reported its financial...
© 2024 - Koa.international. All Rights Reserved.